Medical Device Consultants in High Demand as FDA and EU Rejection Rates Rise

Increasing rejection rates in global regulatory approvals are driving demand for medical device consultants, as manufacturers face mounting challenges in entering US and European markets.

"Regulatory compliance is no longer a final step it must begin at the design stage," says Mr Soio George, Project Head (Asia Pacific) at I3CGLOBAL. "Manufacturers who delay regulatory planning often face rejections, costly redesigns, and extended timelines."

Traditionally, many companies engaged medical device consultants only at the documentation stage. However, with increasing scrutiny from regulatory authorities such as the US FDA and EU Notified Bodies, this approach is proving ineffective. Early involvement of consultants allows manufacturers to define the correct regulatory pathway, such as FDA 510(k) clearance or CE marking under MDR/IVDR while aligning product design, testing, and clinical evaluation with global requirements.

Experts also point to infrastructure and operational readiness as critical factors in regulatory success. Facility design, cleanroom standards, and production workflows must meet stringent compliance expectations. In addition, implementing a robust Quality Management System (QMS), aligned with standards such as ISO 13485, QMSR, and MDSAP, is essential to ensure consistent product quality and audit readiness.

Beyond systems and processes, the human element plays a vital role. Even well-documented procedures can fail if employees are not adequately trained or if quality culture is not embedded within the organisation. Regulators increasingly assess how processes are implemented in real-world conditions, making workforce preparedness a key determinant of approval outcomes.

The rise of Software as a Medical Device (SaMD) is adding further complexity to the regulatory landscape. Compliance with standards such as IEC 62304, along with cybersecurity and performance validation requirements, is becoming essential for manufacturers developing digital health solutions.

As global regulatory frameworks continue to evolve, manufacturers are recognising that early engagement with experienced medical device consultants can significantly reduce delays, minimise risks, and improve approval success rates.

"Regulatory expertise is now a strategic advantage," Mr George adds. "A compliance-first approach not only accelerates approvals but also strengthens long-term market success."

I3CGlobal
MR-02, D-4, ClayWorks Shankaraa, Bangalore - 560062
enquiry@i3cglobal.com

I3CGLOBAL is a leading medical device consulting firm enabling global market access for manufacturers through FDA 510(k), EU MDR, and IVDR compliance. Known for its end-to-end approach, I3CGLOBAL supports clients from product concept, facility setup, and ISO 13485 implementation to final regulatory approvals. The company's team of medical device consultants specialises in reducing rejection risks, accelerating timelines, and ensuring audit readiness. With proven experience in global submissions and compliance strategy, I3CGLOBAL acts as a trusted partner for companies expanding into regulated markets.

This release was published on openPR.